Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com Prev Post Binding Commitments Received for A$1.0 Million under Convertible Note Placement April 28, 2025 Next Post RHI: Acqn of royalty over Sandstone Gold Project tenements April 28, 2025 Related Posts Standard Uranium Retains 100% Unencumbered Ownership of the Sun Dog Project Through Conclusion of Property Option Agreement December 12, 2025 Apex Provides Corporate Update December 12, 2025 ReeXploration Announces Field Program Results Confirming Large-Scale Uranium Target at Eureka, Namibia December 12, 2025
Standard Uranium Retains 100% Unencumbered Ownership of the Sun Dog Project Through Conclusion of Property Option Agreement December 12, 2025
ReeXploration Announces Field Program Results Confirming Large-Scale Uranium Target at Eureka, Namibia December 12, 2025